Viewing StudyNCT03425201



Ignite Creation Date: 2024-05-06 @ 11:03 AM
Last Modification Date: 2024-10-26 @ 12:39 PM
Study NCT ID: NCT03425201
Status: COMPLETED
Last Update Posted: 2023-12-28
First Post: 2018-02-01

Brief Title: Niraparib in Combination With Cabozantinib XL184 in Patients With Advanced Urothelial Cancer NICARAGUA
Sponsor: Fundacion CRIS de Investigación para Vencer el Cáncer
Organization: Fundacion CRIS de Investigación para Vencer el Cáncer

Organization Data

Organization: Fundacion CRIS de Investigación para Vencer el Cáncer
Class: OTHER
Study ID: NICARAGUA
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Fundacion CRIS de Investigación para Vencer el Cáncer
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Apices Soluciones SL INDUSTRY
Ipsen INDUSTRY
GlaxoSmithKline INDUSTRY